Toragen is focused on repurposing anti-viral drugs and developing novel immunotherapies to treat viral-associated cancers.
Toragen's investors include Bill & Melinda Gates Foundation, GenHenn Venture, Steven Lebow, Scott Rasgon, Paul Engler.
Toragen is headquartered in San Diego, United States.
Toragen is focused on repurposing anti-viral drugs and developing novel immunotherapies to treat viral-associated cancers.
Toragen is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Toragen — Funding & Investors." VCBacked, October 29, 2025, https://www.vcbacked.co/company/toragen. Accessed August 14, 2026.
VCBacked. (2025). Toragen — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/toragen
{{cite web |title=Toragen — Funding & Investors |url=https://www.vcbacked.co/company/toragen |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated